← Browse by Condition
Medical Condition
lymphoproliferative disorders
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2, Phase 3, Phase 2
NCT05770544 Phase 2, Phase 3
Recruiting
DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers.
Enrollment
30 pts
Location
United Kingdom
Sponsor
Cancer Research UK
NCT02579967 Phase 2
Recruiting
Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
Enrollment
354 pts
Location
United States
Sponsor
National Cancer Institute (NCI...